All Stories

  1. Identification of endoplasmic reticulum stress-associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm
  2. NADPH Oxidase 5 (NOX5) Upregulates MMP-10 Production and Cell Migration in Human Endothelial Cells
  3. Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress
  4. PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets
  5. Novel pharmacological approaches in abdominal aortic aneurysm
  6. Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?
  7. Retinal Pigment Epithelium-Secreted VEGF-A Induces Alpha-2-Macroglobulin Expression in Endothelial Cells
  8. Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion
  9. NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond
  10. Targeting Tyrosine Hydroxylase for Abdominal Aortic Aneurysm: Impact on Inflammation, Oxidative Stress, and Vascular Remodeling
  11. Rolipram Prevents the Formation of Abdominal Aortic Aneurysm (AAA) in Mice: PDE4B as a Target in AAA
  12. High NOR-1 (Neuron-Derived Orphan Receptor 1) Expression Strengthens the Vascular Wall Response to Angiotensin II Leading to Aneurysm Formation in Mice
  13. Cells in Cardiovascular Disease: Using Diversity to Confront Adversity
  14. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis
  15. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy
  16. The Role of Lysyl Oxidase Enzymes in Cardiac Function and Remodeling
  17. Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges
  18. Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK
  19. La sobreexpresión vascular de la lisil oxidasa altera la estructura de la matriz extracelular e induce estrés oxidativo
  20. The nuclear receptor NOR-1 regulates vitronectin in human vascular smooth muscle cells
  21. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II–induced hypertrophy
  22. New genetic association for the kinin system: the L-arginine connection
  23. La inflamación inhibe la expresión vascular de la fibulina-5: implicación del factor de transcripción SOX9
  24. NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress
  25. Nestin+ cells direct inflammatory cell migration in atherosclerosis
  26. The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation
  27. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics
  28. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
  29. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats
  30. Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells
  31. miR-17 and -20a Target the Neuron-Derived Orphan Receptor-1 (NOR-1) in Vascular Endothelial Cells
  32. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells
  33. Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm
  34. miR-146a targets Fos expression in human cardiac cells
  35. CALU polymorphism A29809G affects calumenin availability involving vascular calcification
  36. The lysyl oxidase inhibitor  -aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats
  37. HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration
  38. NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation
  39. Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes
  40. Endothelial Krüppel-Like Factor 4 Modulates Pulmonary Arterial Hypertension
  41. El receptor nuclear NOR-1 regula la activación de las células vasculares y el remodelado vascular en respuesta a estrés hemodinámico
  42. Lysyl oxidase (LOX) in vascular remodelling
  43. Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm
  44. A major role for RCAN1 in atherosclerosis progression
  45. Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
  46. Left and Right Ventricle Late Remodeling Following Myocardial Infarction in Rats
  47. Inactivation of Nuclear Factor-Y Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation
  48. Over-expression of Neuron-derived Orphan Receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury
  49. Synergistic Effect of Thrombin and CD40 Ligand on Endothelial Matrix Metalloproteinase-10 Expression and Microparticle Generation In Vitro and In Vivo
  50. Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm
  51. Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients
  52. Imidazolineoxyl N-oxide induces COX-2 in endothelial cells role of free radicals
  53. Deficient p27 Phosphorylation at Serine 10 Increases Macrophage Foam Cell Formation and Aggravates Atherosclerosis Through a Proliferation-Independent Mechanism
  54. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions
  55. CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in Vascular Smooth Muscle Cells: Role of NF- B
  56. HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia
  57. Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli
  58. Hypoxia upregulates PGI-synthase and increases PGI2release in human vascular cells exposed to inflammatory stimuli
  59. Emerging therapeutic strategies to enhance HDL function
  60. Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1α)-dependent Mechanism
  61. New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin
  62. Trans-10 cis-12-CLA dysregulate lipid and glucose metabolism and induce hepatic NR4A receptors
  63. Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation
  64. The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response of Endothelial Cells to Hypoxia
  65. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors
  66. p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats
  67. EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone
  68. Modulation of Endothelium and Endothelial Progenitor Cell Function by Low-Density Lipoproteins: Implication for Vascular Repair, Angiogenesis and Vasculogenesis
  69. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism
  70. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: Effect of simvastatin
  71. Retinoic acid induces PGI synthase expression in human endothelial cells
  72. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases
  73. Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction
  74. Thrombin and protease-activated receptors (PARs) in atherothrombosis
  75. Lysyl oxidase as a potential therapeutic target
  76. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli
  77. Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke
  78. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression
  79. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines
  80. Vascular effects of thrombin: Involvement of NOR-1 in thrombin-induced mitogenic stimulus in vascular cells
  81. Blood-Borne Tissue Factor Activity Predicts Major Cerebrovascular Events in Patients Undergoing Carotid Endarterectomy: Results from a 1-Year Follow-Up Study
  82. Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
  83. Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth
  84. Influence of Statin Use on Endothelial Function: From Bench to Clinics
  85. Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke
  86. Cell Biology and Lipoproteins in Atherosclerosis
  87. Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
  88. Efecto temprano de las estatinas después de un infarto de miocardio. ¿Se debe a los efectos pleiotrópicos?
  89. NOR-1 is involved in VEGF-induced endothelial cell growth
  90. Transcription Factor SOX18 Is Expressed in Human Coronary Atherosclerotic Lesions and Regulates DNA Synthesis and Vascular Cell Growth
  91. Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation
  92. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells
  93. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells
  94. Simvastatin potenciates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL
  95. Involvement of Neuron-Derived Orphan Receptor-1 (NOR-1) in LDL-Induced Mitogenic Stimulus in Vascular Smooth Muscle Cells: Role of CREB
  96. Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC
  97. Modulation of ERG25 expression by LDL in vascular cells
  98. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel–Palade bodies and in human endothelial cells
  99. Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell Proliferation
  100. Neovascularización en arterias coronarias humanas con distintos grados de lesión
  101. Low Density Lipoproteins Downregulate Lysyl Oxidase in Vascular Endothelial Cells and the Arterial Wall
  102. Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor-Related Protein and LDL Receptors
  103. HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels
  104. Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet-released products
  105. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
  106. 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLs : Balance Between Transcriptional and Posttranscriptional Regulation
  107. LDL Downregulates CYP51 in Porcine Vascular Endothelial Cells and in the Arterial Wall Through a Sterol Regulatory Element Binding Protein-2-Dependent Mechanism
  108. Biología celular y molecular de las lesiones ateroscleróticas
  109. LDL Receptor-Related Protein Mediates Uptake of Aggregated LDL in Human Vascular Smooth Muscle Cells
  110. Small oxidative changes in atherogenic LDL concentrations irreversibly regulate adhesiveness of human endothelial cells: effect of the lazaroid U74500A
  111. Reendotelización, engrosamiento intimal y remodelado vascular. ¿Un denominador común?
  112. Regulatory Effects of HDL on Smooth Muscle Cell Prostacyclin Release
  113. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition
  114. Esterified Cholesterol Accumulation Induced by Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells Is Reduced by HMG-CoA Reductase Inhibitors
  115. The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species
  116. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells
  117. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells
  118. HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
  119. Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model
  120. Characterization of a cDNA Encoding a Cytosolic Peptidylprolyl Cis-Trans -Isomerase from Blattella Germanica
  121. Cytochrome c oxidase subunit I from the cockroach Blattella germanica: Cloning, developmental pattern and tissue expression
  122. 3-Hydroxy-3-methylglutaryl-coenzyme-A synthase from Blattella germanica. Cloning, expression, developmental pattern and tissue expression
  123. Molecular cloning, developmental pattern and tissue expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase of the cockroach Blattella germanica